Maria Paola Belfiore Selected Research

Acetylglucosaminidase (NAGase)

1/2015

The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Paola Belfiore Research Topics

Disease

3	COVID-19 10/2023 - 01/2020
2	Neoplasms (Cancer) 02/2023 - 01/2022
2	Mucopolysaccharidosis III (Sanfilippo Syndrome) 01/2020 - 01/2015
2	Pain (Aches) 03/2019 - 01/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2017 - 09/2015
1	Urinary Tract Infections (Urinary Tract Infection) 08/2023
1	Lung Neoplasms (Lung Cancer) 05/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Cardiotoxicity 01/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Thrombophilia 01/2022
1	Hematoma 01/2022
1	Hemorrhage 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Ischemia 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Infections 01/2020
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2020
1	Churg-Strauss Syndrome (Allergic Angiitis) 03/2019
1	Mucopolysaccharidoses 01/2015
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2015
1	Heart Valve Diseases (Valvular Heart Disease) 01/2015
1	Heart Failure 01/2015
1	Fibrosis (Cirrhosis) 01/2015
1	Graves Ophthalmopathy 05/2014
1	Inflammation (Inflammations) 05/2014
1	Adenocarcinoma 01/2009
1	Rectal Neoplasms (Rectal Cancer) 01/2009

Drug/Important Bio-Agent (IBA)

2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2021 - 01/2020
2	EnzymesIBA 01/2020 - 01/2015
2	alpha-N-acetyl-D-glucosaminidase (alpha-N-acetylglucosaminidase)IBA 01/2020 - 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	IpilimumabIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	NivolumabIBA 01/2022
1	Lysergic Acid Diethylamide (LSD)IBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2019
1	Myosins (Myosin)IBA 01/2015
1	Acetylglucosaminidase (NAGase)IBA 01/2015
1	Beclin-1IBA 01/2015
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2015
1	Connexin 43 (Connexin43)IBA 01/2015
1	Protein Isoforms (Isoforms)IBA 01/2015
1	Natriuretic PeptidesIBA 01/2015
1	CollagenIBA 01/2015
1	ActininIBA 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2015
1	Prednisone (Sone)FDA LinkGeneric 05/2014
1	SteroidsIBA 05/2014

Therapy/Procedure

5	Therapeutics 10/2023 - 05/2014
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2009
3	Radiotherapy 05/2023 - 01/2009
2	Immunotherapy 02/2023 - 01/2022
2	Ablation Techniques 03/2017 - 09/2015
1	Bathroom Equipment 08/2023
1	Proctectomy 01/2009
1	Radiofrequency Ablation 01/2009
1	Palliative Care (Palliative Therapy) 01/2009